Opus Genetics Quote - IRD

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.09

Bid

1.02

Offer

1.11

Volume

60,897

1.03 Day's Range 1.11

0.81 52 Week Range 1.56

Market Cap

34.41M

Previous Close

1.07

Open

1.11

Last Trade

1.09

Last Trade Time

Financial Volume

US$ 64,967

VWAP

1.0668

Average Volume (3m)

220,601

Shares Outstanding

31,568,457

Dividend Yield

PE Ratio

-5.72

Earnings Per Share (EPS)

-0.32

Revenue

19.05M

Net Profit

-9.99M

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol ... Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema. Show more

Sector

Motion Pic, Videotape Prodtn

Industry

Pharmaceutical Preparations

Website

www.ocuphire.com

Headquarters

Wilmington, Delaware, USA

Founded

1999

Opus Genetics Inc is listed in the Motion Pic, Videotape Prodtn sector of the NASDAQ with ticker IRD. The last closing price for Opus Genetics was US$1.07. Over the last year, Opus Genetics shares have traded in a share price range of US$ 0.81 to US$ 1.56.

Opus Genetics currently has 31,568,457 shares in issue. The market capitalisation of Opus Genetics is US$33.78 million. Opus Genetics has a price to earnings ratio (PE ratio) of -5.72.

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.

Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 Months New Leadership is...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-1.8018018018	1.11	1.1432	1.02	162586	1.08028871	CS
4	0.02	1.8691588785	1.07	1.2699	1.02	166849	1.12970083	CS
12	-0.1	-8.40336134454	1.19	1.56	0.81	220601	1.12674409	CS
26	-0.1	-8.40336134454	1.19	1.56	0.81	210542	1.11434322	CS
52	-0.1	-8.40336134454	1.19	1.56	0.81	210542	1.11434322	CS
156	-0.1	-8.40336134454	1.19	1.56	0.81	210542	1.11434322	CS
260	-0.1	-8.40336134454	1.19	1.56	0.81	210542	1.11434322	CS

IRD - Frequently Asked Questions (FAQ)

What is the current Opus Genetics share price?

The current share price of Opus Genetics is US$ 1.09

How many Opus Genetics shares are in issue?

Opus Genetics has 31,568,457 shares in issue

What is the market cap of Opus Genetics?

The market capitalisation of Opus Genetics is USD 33.78M

What is the 1 year trading range for Opus Genetics share price?

Opus Genetics has traded in the range of US$ 0.81 to US$ 1.56 during the past year

What is the PE ratio of Opus Genetics?

The price to earnings ratio of Opus Genetics is -5.72

What is the cash to sales ratio of Opus Genetics?

The cash to sales ratio of Opus Genetics is 3

What is the reporting currency for Opus Genetics?

Opus Genetics reports financial results in USD

What is the latest annual turnover for Opus Genetics?

The latest annual turnover of Opus Genetics is USD 19.05M

What is the latest annual profit for Opus Genetics?

The latest annual profit of Opus Genetics is USD -9.99M

What is the registered address of Opus Genetics?

The registered address for Opus Genetics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Opus Genetics website address?

The website address for Opus Genetics is www.ocuphire.com

Which industry sector does Opus Genetics operate in?

Opus Genetics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TRIThomson Reuters Corporation	US$ 176.39 (780.63%)	461.02k
PEPGPepGen Inc	US$ 2.51 (64.05%)	26.55M
ULYUrgent ly Inc	US$ 0.6715 (59.88%)	154.71M
BCGBinah Capital Group Inc	US$ 2.845 (53.11%)	69.86M
RRGBRed Robin Gourmet Burgers Inc	US$ 6.09 (34.73%)	3.92M
SUNESUNation Energy Inc	US$ 0.4224 (-63.27%)	5.49M
SPGCSacks Parente Golf Inc	US$ 0.401 (-45.23%)	19.69M
DMRCDigimarc Corporation	US$ 15.35 (-43.23%)	1.57M
NXTTNext Technology Holding Inc	US$ 0.77 (-41.22%)	7.2M
ARKOARKO Corporation	US$ 4.515 (-37.81%)	5.83M
NVDANVIDIA Corporation	US$ 120.15 (-8.48%)	443.62M
QNRXQuoin Pharmaceuticals Ltd	US$ 0.356499 (15.82%)	161.75M
ULYUrgent ly Inc	US$ 0.6715 (59.88%)	154.71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 12.465 (-6.21%)	147.14M
TRNRInteractive Strength Inc	US$ 1.525 (22.00%)	126.97M